Outlook Therapeutics
OTLK
OTLK
87 hedge funds and large institutions have $51.1M invested in Outlook Therapeutics in 2023 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 31 increasing their positions, 20 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0.04% more ownership
Funds ownership: 0.53% → 0.57% (+0.04%)
Holders
87
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$2M | |
| 2 | +$1.27M | |
| 3 | +$437K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$319K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$239K |
Top Sellers
| 1 | -$647K | |
| 2 | -$447K | |
| 3 | -$237K | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$108K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$107K |